Taking care of our bodies, especially when we might have a sickness like diabetes, is like being a superhero on a mission. You must find the best tools to help you stay strong and healthy. Today, we will talk about a special tool, a medicine, that doctors give to people with type 2 diabetes. It’s called GLP-1, which is short for glucagon-like peptide 1. But sometimes, people can’t use this medicine, so we have to look at other choices, just like a superhero might need a different gadget if the first one isn’t right.What Is GLP-1?
Among people with type 2 diabetes who received a GLP-1 receptor agonist, there was less correlation between this treatment and thyroid cancer than among people with type 2 diabetes treated with insulin.
The Glucagon-like Peptide-1 (GLP-1) Agonists Market size is estimated at USD 11.87 billion in 2023, and is expected to reach USD 12.55 billion by 2028,.